{"hands_on_practices": [{"introduction": "The first critical step in managing a severe infection is to rapidly achieve a therapeutic concentration of the antibiotic in the bloodstream. This practice focuses on calculating the initial loading dose of an aminoglycoside, a fundamental skill grounded in the pharmacokinetic concept of the volume of distribution ($V_d$). By working through this hypothetical scenario, you will master the core relationship between the desired peak concentration, the patient's size, and the amount of drug needed to effectively \"fill\" the space into which it distributes [@problem_id:4620861].", "problem": "Aminoglycosides such as gentamicin exhibit distribution largely confined to extracellular fluid and are commonly modeled initially by a single, well-mixed compartment for the purpose of calculating an intravenous loading dose. Consider an adult patient with body weight $W = 70$ $\\text{kg}$ who is to receive gentamicin as an intravenous (IV) bolus or short infusion. The clinical goal is to achieve a peak serum concentration (maximum concentration) $C_{\\max} = 8$ $\\text{mg}/\\text{L}$ measured at distribution equilibrium after the end of infusion. The typical volume of distribution (defined as the ratio of the amount of drug in the body at distribution equilibrium to the corresponding plasma concentration at that time) for gentamicin in adults can be taken as $V_{d} = 0.25$ $\\text{L}/\\text{kg}$.\n\nStarting only from (i) mass balance for an IV dose, (ii) the definition of volume of distribution $V_{d}$ as the ratio $A/C$ at distribution equilibrium, and (iii) the concept that immediately after administration and distribution the amount of drug in the body $A$ is approximately equal to the administered dose for an IV dose, derive the expression for the IV loading dose that would achieve the target $C_{\\max}$ in this patient. Then, compute the numerical value of the loading dose using the provided parameters. Explicitly state any physiological or pharmacokinetic assumptions about distribution that are necessary for your derivation to hold.\n\nExpress the final dose in $\\text{mg}$ and round your numerical result to three significant figures. Provide only the final numerical value in your answer box.", "solution": "The problem statement must first be validated for scientific soundness, self-consistency, and clarity before a solution is attempted.\n\n### Step 1: Extract Givens\nThe verbatim givens extracted from the problem statement are:\n-   Patient body weight: $W = 70$ $\\text{kg}$\n-   Target peak serum concentration: $C_{\\max} = 8$ $\\text{mg}/\\text{L}$\n-   Volume of distribution (specific to body weight): $V_{d} = 0.25$ $\\text{L}/\\text{kg}$\n-   Dosage form: Intravenous (IV) bolus or short infusion\n-   Pharmacokinetic model: Single, well-mixed compartment\n-   Core definition 1: Volume of distribution is the ratio $A/C$, where $A$ is the amount of drug in the body and $C$ is the plasma concentration at distribution equilibrium.\n-   Core concept 2: Immediately after administration and distribution, the amount of drug in the body $A$ is approximately equal to the administered IV dose.\n-   Task 1: Derive the expression for the IV loading dose.\n-   Task 2: Compute the numerical value of the loading dose.\n-   Task 3: State the necessary physiological or pharmacokinetic assumptions.\n-   Final Answer Specification: The numerical result must be in units of $\\text{mg}$ and rounded to three significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed against the validation criteria.\n-   **Scientifically Grounded**: The problem is based on the fundamental principles of pharmacokinetics, specifically the one-compartment model for drug distribution. This model is a standard and widely used simplification for calculating loading doses for drugs like aminoglycosides, which primarily distribute into the extracellular fluid. The provided values for volume of distribution ($0.25$ $\\text{L}/\\text{kg}$) and target concentration ($8$ $\\text{mg}/\\text{L}$) for gentamicin are clinically realistic. The problem is free of pseudoscience and is grounded in established pharmacological theory.\n-   **Well-Posed**: The problem provides all necessary data ($W$, $C_{\\max}$, $V_{d}$) and definitions required to derive the formula and compute a unique numerical answer. The objective is clearly stated.\n-   **Objective**: The problem is stated in precise, objective, and technical language common to pharmacology and medicine. There are no subjective or ambiguous terms.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. It is scientifically sound, well-posed, and objective. There are no contradictions, missing information, or logical flaws. The solution process will now proceed.\n\n### Solution Derivation\nThe objective is to derive an expression for the loading dose, $D_{L}$, that achieves a target peak concentration, $C_{\\max}$, immediately following IV administration and distribution.\n\n1.  The volume of distribution, $V_{d}$, is given as a specific volume per unit of body weight. The total volume of distribution for the patient, which we will denote as $V_{d, \\text{total}}$, is calculated by multiplying the specific volume by the patient's weight $W$.\n    $$V_{d, \\text{total}} = V_{d} \\times W$$\n\n2.  The problem provides the definition of the volume of distribution as the ratio of the amount of drug in the body, $A$, to the concentration in the plasma, $C$, at distribution equilibrium.\n    $$V_{d, \\text{total}} = \\frac{A}{C}$$\n\n3.  The clinical goal is to achieve a peak concentration $C_{\\max}$ at distribution equilibrium. At this specific point in time, the concentration $C$ is equal to $C_{\\max}$, and the amount of drug in the body is $A$. The relationship is:\n    $$C_{\\max} = \\frac{A}{V_{d, \\text{total}}}$$\n\n4.  The problem states that for an IV dose, we can assume that the amount of drug in the body, $A$, immediately after administration and distribution is approximately equal to the administered loading dose, $D_{L}$. This is a key assumption based on the idea that distribution is rapid and elimination is negligible over this short period.\n    $$A \\approx D_{L}$$\n\n5.  By substituting $D_{L}$ for $A$ in the concentration equation, we can relate the loading dose directly to the target peak concentration.\n    $$C_{\\max} \\approx \\frac{D_{L}}{V_{d, \\text{total}}}$$\n\n6.  To find the expression for the loading dose, we rearrange the equation:\n    $$D_{L} \\approx C_{\\max} \\times V_{d, \\text{total}}$$\n\n7.  Finally, substituting the expression for $V_{d, \\text{total}}$ from step 1 gives the complete derived expression for the loading dose:\n    $$D_{L} \\approx C_{\\max} \\times V_{d} \\times W$$\n\n### Statement of Assumptions\nAs required by the problem, the derivation relies on the following key pharmacokinetic assumptions:\n1.  **Single-Compartment Model**: The drug is assumed to distribute instantaneously and uniformly throughout a single, well-mixed volume (the volume of distribution). This implies that the drug concentration is the same throughout this conceptual compartment once distribution is complete.\n2.  **Negligible Elimination During Distribution**: It is assumed that no significant amount of the drug is eliminated (by metabolism or excretion) from the body during the administration and immediate post-administration distribution phase. This allows the amount of drug in the body at peak concentration to be equated to the total dose administered. This assumption is most valid for a rapid IV bolus injection.\n\n### Numerical Calculation\nThe derived expression is now used to compute the numerical value of the loading dose using the given parameters.\n\n-   $C_{\\max} = 8$ $\\text{mg}/\\text{L}$\n-   $V_{d} = 0.25$ $\\text{L}/\\text{kg}$\n-   $W = 70$ $\\text{kg}$\n\n$$D_{L} = (8 \\text{ mg}/\\text{L}) \\times (0.25 \\text{ L}/\\text{kg}) \\times (70 \\text{ kg})$$\nThe units are consistent: $(\\text{mg}/\\text{L}) \\times (\\text{L}/\\text{kg}) \\times \\text{kg} = \\text{mg}$.\n\n$$D_{L} = (8 \\times 0.25 \\times 70) \\text{ mg}$$\n$$D_{L} = (2 \\times 70) \\text{ mg}$$\n$$D_{L} = 140 \\text{ mg}$$\n\nThe problem requires the final answer to be rounded to three significant figures. The exact calculated value is $140$. To express this value unambiguously with three significant figures, it is written in scientific notation as $1.40 \\times 10^2$.", "answer": "$$\\boxed{1.40 \\times 10^{2}}$$", "id": "4620861"}, {"introduction": "Once a therapeutic level is achieved, the focus shifts to maintaining it, which requires understanding how the body eliminates the drug. For aminoglycosides, elimination is almost entirely dependent on renal function, making it a critical factor in preventing toxicity. This exercise demonstrates how to connect a common clinical measure of kidney function, creatinine clearance ($CL_{Cr}$), to the drug's systemic clearance ($CL$) and ultimately its elimination half-life ($t_{1/2}$), which dictates the appropriate dosing interval [@problem_id:4620944].", "problem": "Aminoglycosides are predominantly eliminated by the kidney and, in patients with stable renal function, their systemic clearance can be approximated as a fixed fraction of creatinine clearance. Consider gentamicin in a single-compartment, first-order elimination framework where the amount of drug in the body, denoted by $A(t)$, obeys the differential equation $dA/dt = -k\\,A(t)$, with $k$ the first-order elimination rate constant. Let systemic clearance be denoted by $CL$, volume of distribution by $V_{d}$, and half-life by $t_{1/2}$, defined as the time required for $A(t)$ to decrease to $A(0)/2$. Use the foundational pharmacokinetic identity $CL = k\\,V_{d}$ and the definition of half-life arising from first-order decay, together with the clinical approximation that gentamicin clearance is $CL \\approx f \\cdot CL_{\\text{Cr}}$, where $f = 0.8$ and $CL_{\\text{Cr}}$ is creatinine clearance (CrCl).\n\nFor a patient of mass $60$ $\\mathrm{kg}$ receiving gentamicin, suppose the creatinine clearance is $40$ $\\mathrm{mL}/\\mathrm{min}$ and the gentamicin volume of distribution is $V_{d} = 0.25$ $\\mathrm{L}/\\mathrm{kg}$. Starting from the stated first principles and identities, derive an expression for $t_{1/2}$ and then compute its numerical value for this patient. Express your final answer in $\\mathrm{hours}$ and round your answer to four significant figures.", "solution": "The problem is to derive an expression for the pharmacokinetic half-life, $t_{1/2}$, and compute its numerical value for a specific patient receiving gentamicin. The solution process begins by validating the problem statement.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\nThe givens are:\n- The differential equation for the amount of drug in the body, $A(t)$, is $\\frac{dA}{dt} = -k\\,A(t)$.\n- $k$ is the first-order elimination rate constant.\n- The half-life, $t_{1/2}$, is defined as the time at which $A(t_{1/2}) = \\frac{A(0)}{2}$.\n- The pharmacokinetic identity relating systemic clearance ($CL$), elimination rate constant ($k$), and volume of distribution ($V_d$) is $CL = k\\,V_{d}$.\n- The clinical approximation for gentamicin clearance is $CL \\approx f \\cdot CL_{\\text{Cr}}$, where $CL_{\\text{Cr}}$ is the creatinine clearance.\n- The proportionality constant is $f = 0.8$.\n- The patient's mass is $m = 60$ $\\mathrm{kg}$.\n- The patient's creatinine clearance is $CL_{\\text{Cr}} = 40$ $\\mathrm{mL}/\\mathrm{min}$.\n- The patient's gentamicin volume of distribution is $V_{d} = 0.25$ $\\mathrm{L}/\\mathrm{kg}$.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is scientifically grounded, as it is based on the standard one-compartment model with first-order elimination, a fundamental concept in pharmacokinetics. The provided equations and relationships are standard definitions and models in the field. The clinical approximation for aminoglycoside clearance is a widely used heuristic in medicine. The problem is well-posed, as all necessary data and relationships are provided to calculate a unique solution. The language is objective and quantitative. Therefore, the problem is valid.\n\n**Step 3: Verdict and Action**\nThe problem is deemed valid. We will proceed with the solution.\n\n### Derivation of the Half-Life Expression\n\nWe begin with the governing differential equation for first-order elimination:\n$$ \\frac{dA}{dt} = -k\\,A(t) $$\nThis is a separable first-order linear ordinary differential equation. We can solve it by separating variables and integrating:\n$$ \\int_{A(0)}^{A(t)} \\frac{dA}{A} = \\int_{0}^{t} -k\\,dt' $$\n$$ \\ln(A(t)) - \\ln(A(0)) = -kt $$\n$$ \\ln\\left(\\frac{A(t)}{A(0)}\\right) = -kt $$\nExponentiating both sides gives the solution for $A(t)$:\n$$ A(t) = A(0) \\exp(-kt) $$\nBy definition, the half-life, $t_{1/2}$, is the time it takes for the amount of drug to be reduced to half of its initial value, $A(0)$. We set $t = t_{1/2}$ and $A(t_{1/2}) = \\frac{A(0)}{2}$:\n$$ \\frac{A(0)}{2} = A(0) \\exp(-k t_{1/2}) $$\nDividing by $A(0)$ gives:\n$$ \\frac{1}{2} = \\exp(-k t_{1/2}) $$\nTaking the natural logarithm of both sides:\n$$ \\ln\\left(\\frac{1}{2}\\right) = -k t_{1/2} $$\n$$ -\\ln(2) = -k t_{1/2} $$\nSolving for $t_{1/2}$, we obtain the standard expression for first-order half-life:\n$$ t_{1/2} = \\frac{\\ln(2)}{k} $$\nThe problem provides the pharmacokinetic identity $CL = k\\,V_{d}$. We can rearrange this to express the elimination rate constant $k$ in terms of clearance $CL$ and volume of distribution $V_{d}$:\n$$ k = \\frac{CL}{V_{d}} $$\nSubstituting this expression for $k$ into our equation for $t_{1/2}$ yields the desired expression in terms of the clinically relevant parameters $CL$ and $V_{d}$:\n$$ t_{1/2} = \\frac{\\ln(2)}{CL/V_{d}} = \\frac{V_{d} \\ln(2)}{CL} $$\n\n### Numerical Computation for the Patient\n\nNext, we compute the numerical value of $t_{1/2}$ for the given patient.\n\nFirst, we calculate the patient's total volume of distribution, $V_{d, \\text{total}}$. The problem states the volume of distribution per unit mass is $0.25$ $\\mathrm{L}/\\mathrm{kg}$ and the patient's mass is $60$ $\\mathrm{kg}$.\n$$ V_{d, \\text{total}} = (0.25 \\, \\mathrm{L}/\\mathrm{kg}) \\times (60 \\, \\mathrm{kg}) = 15 \\, \\mathrm{L} $$\n\nSecond, we calculate the patient's gentamicin systemic clearance, $CL$, using the clinical approximation $CL \\approx f \\cdot CL_{\\text{Cr}}$. The given values are $f = 0.8$ and $CL_{\\text{Cr}} = 40$ $\\mathrm{mL}/\\mathrm{min}$.\n$$ CL = f \\cdot CL_{\\text{Cr}} = 0.8 \\times 40 \\, \\mathrm{mL}/\\mathrm{min} = 32 \\, \\mathrm{mL}/\\mathrm{min} $$\n\nThe final answer for $t_{1/2}$ is required in hours. We must ensure consistent units before performing the final calculation. The volume of distribution is in liters ($L$), and the clearance is in milliliters per minute ($\\mathrm{mL}/\\mathrm{min}$). We will convert the clearance to liters per hour ($\\mathrm{L}/\\mathrm{hr}$).\n$$ 1 \\, \\mathrm{L} = 1000 \\, \\mathrm{mL} $$\n$$ 1 \\, \\mathrm{hr} = 60 \\, \\mathrm{min} $$\nSo, we convert $CL$:\n$$ CL = 32 \\, \\frac{\\mathrm{mL}}{\\mathrm{min}} \\times \\frac{1 \\, \\mathrm{L}}{1000 \\, \\mathrm{mL}} \\times \\frac{60 \\, \\mathrm{min}}{1 \\, \\mathrm{hr}} = \\frac{32 \\times 60}{1000} \\, \\frac{\\mathrm{L}}{\\mathrm{hr}} = 1.92 \\, \\frac{\\mathrm{L}}{\\mathrm{hr}} $$\n\nNow we have $V_{d, \\text{total}} = 15$ $\\mathrm{L}$ and $CL = 1.92$ $\\mathrm{L}/\\mathrm{hr}$. We can substitute these values into our derived expression for $t_{1/2}$:\n$$ t_{1/2} = \\frac{V_{d, \\text{total}} \\ln(2)}{CL} = \\frac{15 \\, \\mathrm{L} \\times \\ln(2)}{1.92 \\, \\mathrm{L}/\\mathrm{hr}} $$\nThe units $\\mathrm{L}$ cancel, leaving hours, as required. Using the value $\\ln(2) \\approx 0.693147$:\n$$ t_{1/2} = \\frac{15 \\times 0.693147...}{1.92} \\, \\mathrm{hr} \\approx \\frac{10.3972...}{1.92} \\, \\mathrm{hr} \\approx 5.41521... \\, \\mathrm{hr} $$\nThe problem requires the answer to be rounded to four significant figures.\n$$ t_{1/2} \\approx 5.415 \\, \\mathrm{hr} $$", "answer": "$$\\boxed{5.415}$$", "id": "4620944"}, {"introduction": "While population-based models provide excellent starting points for dosing, the gold standard in aminoglycoside therapy is to tailor the regimen to the individual patient's unique physiology. This advanced practice simulates the process of therapeutic drug monitoring (TDM), where measured serum concentrations are used to calculate patient-specific pharmacokinetic parameters like the elimination rate constant ($k$) and volume of distribution ($V_d$). You will apply these individualized parameters to design a new, optimized dose that precisely meets both efficacy (peak) and safety (trough) targets, representing the integration of pharmacokinetic theory and clinical practice [@problem_id:4620901].", "problem": "A critically ill adult with gram-negative bacteremia is being treated with the aminoglycoside gentamicin by intermittent intravenous (IV) infusion. Assume a one-compartment model with first-order elimination and that the measured concentrations at $t = 1$ hour and $t = 6$ hours after the end of infusion lie in the post-distribution phase. The previous gentamicin dose was 350 mg infused over 0.5 hours. Two serum concentrations were obtained at $t = 1$ hour and $t = 6$ hours post-infusion: 14.4 mg/L and 4.3 mg/L, respectively.\n\nStarting from the mass-balance framework for a one-compartment system with zero-order input during infusion and first-order elimination, and the definition of first-order elimination $dC/dt = -k\\,C$, do the following:\n\n1. Using log-linear regression of post-infusion concentrations, estimate the elimination rate constant $k$ from the two measured points.\n2. Back-extrapolate to estimate the end-of-infusion concentration $C_{0}$ (defined at $t = 0$ immediately after the infusion stops).\n3. Using the standard constant-rate infusion relation between dose, volume of distribution, and end-of-infusion concentration, derive and compute the patientâ€™s apparent volume of distribution $V_{d}$.\n4. The pharmacotherapy goal is a post-distribution peak of 16 mg/L at $t_{p} = 0.5$ hours after the end of infusion for the next dose, with a dosing interval $\\tau = 24$ hours and a maximum acceptable pre-dose trough of 0.5 mg/L. Assuming the same $k$, $V_{d}$, and infusion duration $T_{\\text{inf}} = 0.5$ hours, determine the single next dose that achieves the 16 mg/L peak target at $t_{p} = 0.5$ hours post-infusion. Confirm that the resulting predicted pre-dose trough at $t = \\tau - T_{\\text{inf}}$ satisfies the maximum trough constraint; if it does not, state why no single dose can meet both constraints without changing $\\tau$.\n\nExpress the final next dose in mg and round your answer to three significant figures. If any intermediate numerical values are computed, you may carry additional significant figures to minimize round-off error, but the final reported dose must follow the specified rounding rule and unit.", "solution": "The user wants me to solve a problem. I will now follow the user's instructions.\n### Step 1: Extract Givens\n-   Model: One-compartment, first-order elimination ($dC/dt = -k\\,C$), zero-order input during infusion.\n-   Previous dose, $D_{\\text{prev}}$: $350$ mg.\n-   Infusion duration, $T_{\\text{inf}}$: $0.5$ hours.\n-   Post-infusion concentration at $t_1 = 1$ hour: $C_1 = 14.4$ mg/L.\n-   Post-infusion concentration at $t_2 = 6$ hours: $C_2 = 4.3$ mg/L.\n-   Time points $t_1$ and $t_2$ are in the post-distribution phase. Time $t=0$ is defined as the moment the infusion stops.\n-   Pharmacotherapy goal for the next dose:\n    -   Target peak concentration, $C_{\\text{peak,target}}$: $16$ mg/L.\n    -   Time of target peak, $t_p$: $0.5$ hours after the end of infusion.\n    -   Dosing interval, $\\tau$: $24$ hours.\n    -   Maximum acceptable pre-dose trough, $C_{\\text{trough,max}}$: $0.5$ mg/L.\n-   Assumptions for the next dose calculation: $k$, $V_d$, and $T_{\\text{inf}}$ remain the same.\n\n### Step 2: Validate Using Extracted Givens\n-   **Scientifically Grounded**: The problem is based on a standard one-compartment pharmacokinetic model, which is a fundamental and widely used tool for therapeutic drug monitoring, especially for aminoglycosides like gentamicin. The data ($C_1$, $C_2$, dose) and target concentrations are clinically realistic. The methodology requested (log-linear regression, back-extrapolation, and dose calculation using the infusion formula) is standard practice in clinical pharmacokinetics.\n-   **Well-Posed**: The problem is well-defined and self-contained. It provides sufficient data ($2$ concentration-time points, dose, infusion time) to determine the requested parameters ($k$, $C_0$, $V_d$) and the subsequent new dose. The objectives are clear and lead to a unique solution.\n-   **Objective**: The problem is stated in precise, quantitative, and objective language, free of ambiguity or subjective claims.\n\n### Step 3: Verdict and Action\nThe problem is valid as it is scientifically grounded, well-posed, and objective. I will proceed with the solution.\n\nThe solution is developed by following the four parts of the problem statement.\n\nThe post-infusion concentration decay is governed by first-order elimination. The differential equation is:\n$$\n\\frac{dC}{dt} = -kC\n$$\nwhere $C$ is the drug concentration and $k$ is the elimination rate constant. Integrating this equation gives the concentration $C(t)$ at a time $t$ after the end of infusion:\n$$\nC(t) = C_0 \\exp(-kt)\n$$\nwhere $C_0$ is the concentration at $t=0$ (immediately after the infusion stops). Taking the natural logarithm of this equation linearizes it:\n$$\n\\ln(C(t)) = \\ln(C_0) - kt\n$$\n\n**1. Estimate the elimination rate constant, $k$**\n\nUsing the two given post-infusion data points, $(t_1, C_1) = (1 \\text{ hr}, 14.4 \\text{ mg/L})$ and $(t_2, C_2) = (6 \\text{ hr}, 4.3 \\text{ mg/L})$, we can solve for $k$. The slope of the line on a semi-log plot is $-k$.\n$$\nk = -\\frac{\\ln(C_2) - \\ln(C_1)}{t_2 - t_1} = \\frac{\\ln(C_1) - \\ln(C_2)}{t_2 - t_1}\n$$\nSubstituting the given values:\n$$\nk = \\frac{\\ln(14.4) - \\ln(4.3)}{6 - 1} = \\frac{\\ln\\left(\\frac{14.4}{4.3}\\right)}{5} \\approx \\frac{1.2086}{5} \\approx 0.24172 \\, \\mathrm{hr}^{-1}\n$$\nWe will carry extra precision for intermediate calculations. Let $k \\approx 0.2417206 \\, \\mathrm{hr}^{-1}$.\n\n**2. Back-extrapolate to estimate the end-of-infusion concentration, $C_0$**\n\nUsing the relationship $\\ln(C(t)) = \\ln(C_0) - kt$, we can solve for $C_0$ using one of the data points. Using $(t_1, C_1)$:\n$$\n\\ln(C_0) = \\ln(C_1) + k t_1\n$$\n$$\nC_0 = C_1 \\exp(k t_1)\n$$\nSubstituting the values:\n$$\nC_0 = 14.4 \\times \\exp(0.2417206 \\times 1) = 14.4 \\times \\exp(0.2417206) \\approx 14.4 \\times 1.27344 \\approx 18.3375 \\, \\mathrm{mg/L}\n$$\nLet's use $C_0 \\approx 18.3375 \\, \\mathrm{mg/L}$ for the next step.\n\n**3. Compute the apparent volume of distribution, $V_d$**\n\nFor a short, zero-order intravenous infusion, the concentration at the end of the infusion ($t=T_{\\text{inf}}$, which corresponds to our $t=0$ post-infusion time point) is given by:\n$$\nC_0 = \\frac{D}{V_d k T_{\\text{inf}}} (1 - \\exp(-k T_{\\text{inf}}))\n$$\nRearranging this equation to solve for the volume of distribution, $V_d$:\n$$\nV_d = \\frac{D}{C_0 k T_{\\text{inf}}} (1 - \\exp(-k T_{\\text{inf}}))\n$$\nSubstituting the known values: $D = 350$ mg, $C_0 \\approx 18.3375$ mg/L, $k \\approx 0.2417206 \\, \\mathrm{hr}^{-1}$, and $T_{\\text{inf}} = 0.5$ hr:\n$$\nV_d = \\frac{350}{18.3375 \\times 0.2417206 \\times 0.5} (1 - \\exp(-0.2417206 \\times 0.5))\n$$\n$$\nV_d = \\frac{350}{2.21659} (1 - \\exp(-0.1208603)) \\approx 157.90 \\times (1 - 0.886162) \\approx 157.90 \\times 0.113838 \\approx 17.975 \\, \\mathrm{L}\n$$\nLet's use $V_d \\approx 17.975 \\, \\mathrm{L}$.\n\n**4. Determine the next dose, $D_{\\text{new}}$, and check the trough constraint**\n\nThe goal is to achieve a target peak concentration of $C_{\\text{peak,target}} = 16$ mg/L at a time $t_p = 0.5$ hours after the infusion ends. First, we determine the required concentration at the end of the new infusion, let's call it $C'_{\\text{0,end}}$, that would decay to $16$ mg/L after $0.5$ hours.\n$$\nC_{\\text{peak,target}} = C'_{\\text{0,end}} \\exp(-k t_p)\n$$\n$$\nC'_{\\text{0,end}} = C_{\\text{peak,target}} \\exp(k t_p) = 16 \\times \\exp(0.2417206 \\times 0.5) = 16 \\times \\exp(0.1208603) \\approx 16 \\times 1.12846 \\approx 18.0554 \\, \\mathrm{mg/L}\n$$\nNow, we calculate the new dose, $D_{\\text{new}}$, required to achieve this end-of-infusion concentration, $C'_{\\text{0,end}}$, using the patient's pharmacokinetic parameters ($V_d$, $k$) and the same infusion time $T_{\\text{inf}}$.\n$$\nC'_{\\text{0,end}} = \\frac{D_{\\text{new}}}{V_d k T_{\\text{inf}}} (1 - \\exp(-k T_{\\text{inf}}))\n$$\nSolving for $D_{\\text{new}}$:\n$$\nD_{\\text{new}} = C'_{\\text{0,end}} \\times V_d \\times \\frac{k T_{\\text{inf}}}{1 - \\exp(-k T_{\\text{inf}})}\n$$\nSubstituting the calculated values:\n$$\nD_{\\text{new}} = 18.0554 \\times 17.975 \\times \\frac{0.2417206 \\times 0.5}{1 - \\exp(-0.2417206 \\times 0.5)}\n$$\n$$\nD_{\\text{new}} \\approx 324.55 \\times \\frac{0.1208603}{0.113838} \\approx 324.55 \\times 1.06168 \\approx 344.59 \\, \\mathrm{mg}\n$$\nThe problem requires rounding the final answer to three significant figures.\n$$\nD_{\\text{new}} \\approx 345 \\, \\mathrm{mg}\n$$\nFinally, we must confirm that this dose, which is designed to meet the peak target, also satisfies the trough constraint. The predicted pre-dose trough concentration, $C'_{\\text{trough}}$, is the concentration at time $t = \\tau - T_{\\text{inf}}$ after the end of the infusion, where $\\tau = 24$ hours is the dosing interval.\n$$\nC'_{\\text{trough}} = C'_{\\text{0,end}} \\exp(-k (\\tau - T_{\\text{inf}}))\n$$\n$$\nC'_{\\text{trough}} = 18.0554 \\times \\exp(-0.2417206 \\times (24 - 0.5)) = 18.0554 \\times \\exp(-0.2417206 \\times 23.5)\n$$\n$$\nC'_{\\text{trough}} = 18.0554 \\times \\exp(-5.6804) \\approx 18.0554 \\times 0.00341 \\approx 0.0616 \\, \\mathrm{mg/L}\n$$\nThe maximum acceptable trough concentration is $C_{\\text{trough,max}} = 0.5$ mg/L. Since our predicted trough $C'_{\\text{trough}} \\approx 0.0616$ mg/L is less than $0.5$ mg/L, the trough constraint is satisfied. The calculated dose of $345$ mg is therefore appropriate to meet the specified peak target while respecting the trough limit.", "answer": "$$\\boxed{345}$$", "id": "4620901"}]}